However, although a pathogenic role in intestine inflammation has been ascribed to Th17 cells, administration of neutralizing anti-IL-17A antibody to patients with Crohn’s disease did not show any therapeutic benefit (44). The gene discussed is IL17A; the disease is Crohn disease.